Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice.
Iwamoto H, Shimose S, Noda Y, Shirono T, Niizeki T, Nakano M, Okamura S, Kamachi N, Suzuki H, Sakai M, Kajiwara A, Itano S, Tanaka M, Yamaguchi T, Kuromatsu R, Koga H, Torimura T, On Behalf Of The Kurume Liver Cancer Study Group Of Japan.
Iwamoto H, et al. Among authors: itano s.
Cancers (Basel). 2021 Jun 3;13(11):2786. doi: 10.3390/cancers13112786.
Cancers (Basel). 2021.
PMID: 34205099
Free PMC article.